Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Schüler, Susanne ^a   Lattrich, Claus ^a   Skrzypczak, Maciej ^b   Fehm, Tanja ^c   Ortmann, Olaf ^a   Treeck, Oliver ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Case control study; icb 1 gene; Ovarian cancer; Single nucleotide polymorphism

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; ICB 1 GENE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; DNA SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEOPLASM; OVARY TUMOR; RISK FACTOR;

C1ORF38 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR PROTEIN;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84900811329     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-7-42     Document Type: Article

References (26)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. Langdon SP, Hirst GL, Miller EP, Hawkins RA, Tesdale AL, Smyth JF, Miller WR, J Steroid Biochem Mol Biol 1994 50 131 135 10.1016/0960-0760(94)90019-1 8049141 (Pubitemid 24265224)
3. Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. Galtier-Dereure F, Capony F, Maudelonde T, Rochefort H, J Clin Endocrinol Metab 1992 75 1497 1502 1464654 (Pubitemid 23001410)
4. Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines. Bollmann J, Ortmann O, Treeck O, J Steroid Biochem Mol Biol 2008 109 16 21 10.1016/j.jsbmb.2007.12. 007 18206364
5. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells. Konwisorz A, Springwald A, Haselberger M, Goerse R, Ortmann O, Treeck O, Endocr Relat Cancer 2010 17 147 157 10.1677/ERC-09-0095 19942713
6. A novel basement membrane-induced gene identified in the human endometrial adenocarcinoma cell line HEC1B. Treeck O, Strunck E, Vollmer G, FEBS Lett 1998 425 426 430 10.1016/S0014-5793(98)00278-6 9563507 (Pubitemid 28178845)
7. Icb1Gene counteracts growth of ovarian cancer cell lines. Treeck O, Schuler S, Haring J, Skrzypczak M, Lattrich C, Ortmann O, Cancer Lett 2013 335 441 446 10.1016/j.canlet.2013.02.049 23474491
8. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Lazennec G, Cancer Lett 2006 231 151 157 10.1016/j.canlet.2005. 01.021 16399219 (Pubitemid 43038725)
9. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S, Int J Cancer 1999 84 350 353 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0. CO;2-L 10404084 (Pubitemid 29337118)
10. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A, Cancer Genet Cytogenet 2006 165 114 120 10.1016/j.cancergencyto.2005.07.020 16527605 (Pubitemid 43343504)
11. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA, J Biol Chem 2003 278 20490 20499 10.1074/jbc.M211536200 12657623 (Pubitemid 36806345)
12. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW, Cancer Res 2003 63 812 816 12591731 (Pubitemid 36231981)
13. Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Tamaki T, Mori I, Sakurai T, Kakudo K, Anticancer Res 2002 22 1825 1828 12168876 (Pubitemid 34839203)
14. PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells. Alvarez-Millan JJ, Bocos C, Ferrin V, Lucas AR, Ruibal A, Schneider J, Oncology 2002 62 286 290 10.1159/000059577 12065877 (Pubitemid 34639063)
15. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Guillemette C, Millikan RC, Newman B, Housman DE, Cancer Res 2000 60 950 956 10706110 (Pubitemid 30129531)
16. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, Zillikens MC, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG, Eur J Endocrinol 2005 153 327 334 10.1530/eje.1.01973 16061840 (Pubitemid 41167491)
17. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Tempfer CB, Schneeberger C, Huber JC, Pharmacogenomics 2004 5 57 65 10.1517/phgs.5.1.57.25687 14683420 (Pubitemid 38088480)
18. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K, Cancer Res 2004 64 8891 8900 10.1158/0008-5472.CAN- 04-1256 15604249 (Pubitemid 39665494)
19. Endometriosis: the pathophysiology as an estrogen-dependent disease. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H, J Steroid Biochem Mol Biol 2002 83 149 155 10.1016/S0960-0760(02)00260-1 12650711 (Pubitemid 37040651)
20. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM, Cancer Epidemiol Biomarkers Prev 2006 15 551 558 10.1158/1055-9965.EPI-05-0801 16537715
21. Estrogens and epithelial ovarian cancer. Cunat S, Hoffmann P, Pujol P, Gynecol Oncol 2004 94 25 32 10.1016/j.ygyno.2004.03.026 15262115 (Pubitemid 38950494)
22. A single nucleotide polymorphism (A-> G) in intron 3 of IFNgamma gene is associated with asthma. Kumar A, Ghosh B, Genes Immun 2008 9 294 301 10.1038/gene.2008.17 18385742 (Pubitemid 351791484)
23. Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma. Jardin F, Ruminy P, Parmentier F, Picquenot JM, Courel MN, Bertrand P, Buchonnet G, Tilly H, Bastard C, Leukemia 2005 19 1824 1830 10.1038/sj.leu.2403915 16094416 (Pubitemid 41486162)
24. Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase. Crosbie PA, McGown G, Thorncroft MR, O'Donnell PN, Barber PV, Lewis SJ, Harrison KL, Agius RM, Santibanez-Koref MF, Margison GP, Povey AC, Int J Cancer 2008 122 791 795 10.1002/ijc.23059 17957803
25. The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression. Paca-Uccaralertkun S, Damgaard CK, Auewarakul P, Thitithanyanont A, Suphaphiphat P, Essex M, Kjems J, Lee TH, AIDS Res Hum Retroviruses 2006 22 76 82 10.1089/aid.2006.22.76 16438649 (Pubitemid 43204480)
26. Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility. Springwald A, Lattrich C, Seitz S, Ortmann O, Treeck O, Cancer Invest 2009 27 669 672 10.1080/07357900802620877 19308812